FORMULATION AND CHARACTERIZATION OF NANOSTRUCTURED LIPID CARRIERS OF TOLBUTAMIDE FOR THE TREATMENT OF TYPE II DIABETES. (2024). CAHIERS MAGELLANES-NS, 6(2), 7092-7101. http://cahiersmagellanes.com/index.php/CMN/article/view/1040